Workflow
股权受让
icon
Search documents
亚威股份(002559.SZ):拟受让亚威艾欧斯38.5%股权
Ge Long Hui A P P· 2025-12-30 13:38
格隆汇12月30日丨亚威股份(002559.SZ)公布,公司为坚守精密激光加工设备业务的发展,以自有资金 出资人民币4,620,000 元,受让韩国 SM HEAVY INDUSTRIES CO.,LTD(简称"SM重工")持有的江苏亚 威艾欧斯激光科技有限公司(简称"亚威艾欧斯")38.50%股权,并签订《股权买卖合同》。 ...
淳中科技:拟以3000万元受让星河动力0.2143%股份
Xin Lang Cai Jing· 2025-12-19 10:00
淳中科技公告,公司拟以自有资金人民币3000万元受让北京星河动力航天科技股份有限公司92.76万股 份,占星河动力总股本的0.2143%。公司控股股东及实际控制人何仕达先生本次受让星河动力123.68万 股份。公司本次受让股权后将形成与关联人共同投资,构成关联交易。本次交易未构成重大资产重组。 ...
濮耐股份:1000万元受让新疆秦翔15.28%股权
人民财讯12月18日电,濮耐股份(002225)12月18日公告,公司2025年12月16日以公开竞买方式取得希望 投资在兵团公共资源交易平台挂牌出让的其所持新疆秦翔科技有限公司(以下简称"新疆秦翔")15.28% 股权,公司以自有资金1000万元受让上述股权(不含交易手续费等其他费用)。交易完成后,公司对新 疆秦翔的持股比例由52.49%提升至67.77%。本次投资的目的在于进一步提升公司对新疆秦翔的持股比 例,更有效的推动哈勒哈特菱镁矿的开发进度。 转自:证券时报 ...
四川双马:控股股东拟受让一致行动人6.39%公司股份
Xin Lang Cai Jing· 2025-12-17 11:17
四川双马公告称,12月17日,控股股东和谐恒源与一致行动人LCOHC签署协议,LCOHC拟以协议转让 方式,将48,786,912股(占总股本6.39%)无限售流通股转让给和谐恒源,价格22.32元/股,转让款10.89 亿元。转让前,和谐恒源、LCOHC分别持股26.52%、16.55%;转让后,分别持股32.91%、10.16%。本 次转让不涉及减持,控股股东及实际控制人不变。转让需经深交所确认、中证登过户,结果存不确定 性。受让方承诺过户后十八个月内不减持标的股份。 ...
长川科技(300604.SZ):拟通过公开摘牌方式受让大基金二期持有的长川制造33.3333%股权
Ge Long Hui A P P· 2025-12-15 14:10
格隆汇12月15日丨长川科技(300604.SZ)公布,大基金二期拟通过公开挂牌方式转让其持有的长川制造 33.3333%股权,公司拟通过公开摘牌方式受让大基金二期持有的长川制造33.3333%股权。公司第四届 董事会第十四次会议审议通过了《关于拟以公开摘牌方式受让控股子公司少数股东股权暨关联交易的议 案》,同意公司以公开摘牌方式受让国家集成电路产业投资基金二期股份有限公司持有的公司控股子公 司杭州长川智能制造有限公司33.3333%股权,交易底价为46,287万元(最终参与摘牌估值不低于国资评 估备案结果)。同时,董事会提请股东大会授权董事会办理本次拟以公开摘牌方式受让控股子公司少数 股东股权暨关联交易相关事宜。本次股权转让完成后,公司持有长川制造的股权比例由66.6667%变更 为100.0000%,长川制造将成为公司全资子公司。 ...
沃森生物拟受让玉溪沃森11.3043%股权 强化控制
Zhi Tong Cai Jing· 2025-11-28 11:48
Core Viewpoint - Watson Bio (300142.SZ) announced that its subsidiary, Yuxi Watson Biotechnology Co., Ltd., will acquire an 11.3043% stake from minority shareholder Huixiang Yuetai (Tianjin) Investment Partnership (Limited Partnership) for a price of 1.639 billion yuan, enhancing its control and decision-making efficiency over Yuxi Watson [1] Group 1 - The company will acquire an 11.3043% stake in Yuxi Watson from Huixiang Yuetai [1] - The transaction price for the stake is set at 1.639 billion yuan [1] - This acquisition will increase the company's ownership percentage in Yuxi Watson, thereby strengthening its control [1]
沃森生物:拟3.60亿元受让控股子公司2.4793%股权
Xin Lang Cai Jing· 2025-11-28 11:03
Core Viewpoint - Watson Bio announced the acquisition of a 2.4793% stake in its subsidiary Yuxi Watson from Tianjin Lanwo for a price of 359.4985 million yuan, which is expected to enhance control over Yuxi Watson and positively impact the company's performance for the current year, although there are uncertainties involved [1] Financial Summary - Yuxi Watson's projected revenue for 2024 is 2.664 billion yuan and net profit is 254 million yuan [1] - For the first nine months of 2025, Yuxi Watson reported revenue of 1.682 billion yuan and net profit of 269 million yuan [1] Transaction Details - The board meeting for the acquisition is scheduled for November 28, 2025, with payment due by November 30, 2025, and formal transfer of shares upon completion of business registration [1]
步步高投资拟以3000万元入主ST中珠第一大股东
Jing Ji Guan Cha Bao· 2025-11-27 02:02
Group 1 - ST Zhongzhu announced the receipt of a share transfer agreement from Shenzhen Shenshang Holdings Group, where Shenshang plans to transfer 100% equity of its major shareholder, Shenzhen Landi Technology, to Suzhou Bubugao Investment Development for 30 million yuan [1] - After the transfer, Bubugao Investment will hold 380,172,862 shares of ST Zhongzhu, representing 19.08% of the total share capital [1] - Bubugao Investment stated that there are no plans to increase or decrease its stake in the company within the next 12 months, nor are there any major asset restructuring plans [1] Group 2 - On November 14, ST Zhongzhu announced that Qiongcheng Meihua Tenglong Qifei Investment Partnership intends to acquire 10.38% of the company's shares for 403 million yuan [2] - Qiongcheng Meihua Tenglong Qifei Investment Partnership, which is 80% owned by Wu Shichun, expressed confidence in the company's future development prospects and investment value [2] - The partnership aims to actively exercise shareholder rights to improve the company's operations, asset quality, and sustainable profitability [2]
两“90后”受让市值1.57亿元股票
Zheng Quan Shi Bao· 2025-11-07 00:19
Core Insights - The estimated market value of 5.856 million shares of Yixin Tang as of November 6 is approximately 78.6461 million yuan, with a total market value of about 157 million yuan for the two equity transfers [1] Group 1: Shareholder Changes - Ruan Hongxian stated that the reason for the equity transfer is due to internal family asset planning [2] - Ruan Hongxian, the actual controller of Yixin Tang, holds 182 million shares, accounting for 31.74% of the company's total share capital after the transfer [3] - Ruan Shengxiang and Ruan Aixiang, both daughters of Ruan Hongxian, are involved in the equity transfer and will sign a "concerted action agreement" [3] Group 2: Management Background - Ruan Aixiang has been appointed as the vice president of Yixin Tang and has been working in the company for a long time [3] - Ruan Shengxiang, born in January 1992, holds multiple positions including chairman of the Yunnan Shengai Traditional Chinese Medicine Foundation and vice president of the Yunnan Youth Entrepreneurs Association [4] - The Yunnan Shengai Traditional Chinese Medicine Foundation, established in October 2015, aims to promote traditional Chinese medicine culture and academic research [4]
汉威科技:拟受让重庆斯太宝合计约25.70%股权并对其进行增资
Mei Ri Jing Ji Xin Wen· 2025-10-17 11:39
Group 1 - Hanwei Technology announced on October 17 that it signed an equity transfer and capital increase agreement with several parties, including Hu Yi, Wang Zhigang, and others, to acquire approximately 25.70% equity in Chongqing Stabao Technology Co., Ltd. for about 27.9762 million yuan [1] - The company plans to invest an additional 18 million yuan into Chongqing Stabao, with approximately 1.3889 million yuan allocated to registered capital and about 16.6111 million yuan to capital reserves [1] - After the completion of the transaction, Hanwei Technology will hold 35.39% of Chongqing Stabao's equity and, together with its concerted action parties, will control a total of 52.72% of the equity, leading to Chongqing Stabao being included in the company's consolidated financial statements [1]